Which has better valuation and earnings, BLLN or LMRI?

Billiontoone has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Billiontoone $305.11M 15.37 $7.45M $0.70 141.99 Lumexa Imaging $267.73M 4.37 -$47.10M -$0.49 N/A

Does the media prefer BLLN or LMRI?

In the previous week, Billiontoone had 10 more articles in the media than Lumexa Imaging. MarketBeat recorded 12 mentions for Billiontoone and 2 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.17 beat Billiontoone's score of 0.14 indicating that Lumexa Imaging is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Billiontoone 3 Very Positive mention(s) 0 Positive mention(s) 7 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Lumexa Imaging 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer LMRI or OPCH?

In the previous week, Option Care Health had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for Option Care Health and 2 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.31 beat Lumexa Imaging's score of 1.17 indicating that Option Care Health is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Option Care Health 3 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts prefer CRVL or LMRI?

Lumexa Imaging has a consensus price target of $17.33, suggesting a potential upside of 42.31%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than CorVel. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CorVel 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Lumexa Imaging 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 2.67

Which has preferable earnings and valuation, CRVL or LMRI?

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio CorVel $983.74M 3.54 $110.34M $2.25 30.32 Lumexa Imaging $267.73M 4.37 -$47.10M -$0.49 N/A

Does the media favor CRVL or LMRI?

In the previous week, CorVel had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 9 mentions for CorVel and 2 mentions for Lumexa Imaging. CorVel's average media sentiment score of 1.38 beat Lumexa Imaging's score of 1.17 indicating that CorVel is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CorVel 8 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Lumexa Imaging 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor LMRI or AVAH?

In the previous week, Aveanna Healthcare had 9 more articles in the media than Lumexa Imaging. MarketBeat recorded 11 mentions for Aveanna Healthcare and 2 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.17 beat Aveanna Healthcare's score of 1.14 indicating that Lumexa Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Aveanna Healthcare 8 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger valuation and earnings, LMRI or WGS?

GeneDx has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Lumexa Imaging $267.73M 4.37 -$47.10M -$0.49 N/A GeneDx $454.43M 5.64 -$21.02M -$3.64 N/A

Does the media favor LMRI or WGS?

In the previous week, Lumexa Imaging had 1 more articles in the media than GeneDx. MarketBeat recorded 2 mentions for Lumexa Imaging and 1 mentions for GeneDx. GeneDx's average media sentiment score of 1.73 beat Lumexa Imaging's score of 1.17 indicating that GeneDx is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Lumexa Imaging 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive GeneDx 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive

Lumexa Imaging (LMRI) Competitors

$12.18 +0.28 (+2.35%)

As of 09/4/2026 04:00 PM Eastern

Compare

LMRI vs. BLLN, OPCH, CRVL, AVAH, and WGS

Should you buy Lumexa Imaging stock or one of its competitors? Lumexa Imaging's main competitors and comparable companies include Billiontoone (BLLN), Option Care Health (OPCH), CorVel (CRVL), Aveanna Healthcare (AVAH), and GeneDx (WGS). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Lumexa Imaging compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, earnings, media sentiment, dividends, profitability and analyst recommendations.

In the previous week, Billiontoone had 10 more articles in the media than Lumexa Imaging. MarketBeat recorded 12 mentions for Billiontoone and 2 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.17 beat Billiontoone's score of 0.14 indicating that Lumexa Imaging is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Billiontoone	3 Very Positive mention(s)	0 Positive mention(s)	7 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Lumexa Imaging	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Billiontoone has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Billiontoone	$305.11M	15.37	$7.45M	$0.70	141.99
Lumexa Imaging	$267.73M	4.37	-$47.10M	-$0.49	N/A

Billiontoone has a net margin of 8.04% compared to Lumexa Imaging's net margin of 0.00%. Billiontoone's return on equity of 9.96% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Billiontoone	8.04%	9.96%	5.35%
Lumexa Imaging	N/A	N/A	N/A

Billiontoone currently has a consensus price target of $125.88, indicating a potential upside of 26.65%. Lumexa Imaging has a consensus price target of $17.33, indicating a potential upside of 42.31%. Given Lumexa Imaging's stronger consensus rating and higher probable upside, analysts plainly believe Lumexa Imaging is more favorable than Billiontoone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Billiontoone	2 Sell rating(s)	2 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.45
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Billiontoone beats Lumexa Imaging on 10 of the 14 factors compared between the two stocks.

How does Lumexa Imaging compare to Option Care Health?

Lumexa Imaging (NASDAQ:LMRI) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, risk, analyst recommendations, dividends, valuation, earnings and profitability.

Option Care Health has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.37	-$47.10M	-$0.49	N/A
Option Care Health	$5.65B	0.64	$207.59M	$1.33	18.20

In the previous week, Option Care Health had 3 more articles in the media than Lumexa Imaging. MarketBeat recorded 5 mentions for Option Care Health and 2 mentions for Lumexa Imaging. Option Care Health's average media sentiment score of 1.31 beat Lumexa Imaging's score of 1.17 indicating that Option Care Health is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Option Care Health	3 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lumexa Imaging presently has a consensus target price of $17.33, suggesting a potential upside of 42.31%. Option Care Health has a consensus target price of $29.92, suggesting a potential upside of 23.60%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than Option Care Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Option Care Health	1 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.43

98.1% of Option Care Health shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by insiders. Comparatively, 1.7% of Option Care Health shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Option Care Health has a net margin of 3.68% compared to Lumexa Imaging's net margin of 0.00%. Option Care Health's return on equity of 18.74% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Option Care Health	3.68%	18.74%	7.25%

Summary

Option Care Health beats Lumexa Imaging on 12 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to CorVel?

CorVel (NASDAQ:CRVL) and Lumexa Imaging (NASDAQ:LMRI) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

CorVel has a net margin of 11.72% compared to Lumexa Imaging's net margin of 0.00%. CorVel's return on equity of 29.92% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CorVel	11.72%	29.92%	17.82%
Lumexa Imaging	N/A	N/A	N/A

51.4% of CorVel shares are held by institutional investors. 39.7% of CorVel shares are held by company insiders. Comparatively, 0.7% of Lumexa Imaging shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

CorVel has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than CorVel, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CorVel	$983.74M	3.54	$110.34M	$2.25	30.32
Lumexa Imaging	$267.73M	4.37	-$47.10M	-$0.49	N/A

Lumexa Imaging has a consensus price target of $17.33, suggesting a potential upside of 42.31%. Given Lumexa Imaging's stronger consensus rating and higher possible upside, analysts clearly believe Lumexa Imaging is more favorable than CorVel.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CorVel	0 Sell rating(s)	1 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67

In the previous week, CorVel had 7 more articles in the media than Lumexa Imaging. MarketBeat recorded 9 mentions for CorVel and 2 mentions for Lumexa Imaging. CorVel's average media sentiment score of 1.38 beat Lumexa Imaging's score of 1.17 indicating that CorVel is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
CorVel	8 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Lumexa Imaging	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

CorVel beats Lumexa Imaging on 11 of the 16 factors compared between the two stocks.

How does Lumexa Imaging compare to Aveanna Healthcare?

Lumexa Imaging (NASDAQ:LMRI) and Aveanna Healthcare (NASDAQ:AVAH) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, media sentiment, valuation and risk.

Aveanna Healthcare has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.37	-$47.10M	-$0.49	N/A
Aveanna Healthcare	$2.43B	1.22	$225.03M	$1.23	11.04

Aveanna Healthcare has a net margin of 10.56% compared to Lumexa Imaging's net margin of 0.00%. Aveanna Healthcare's return on equity of 80.70% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
Aveanna Healthcare	10.56%	80.70%	7.42%

88.0% of Aveanna Healthcare shares are held by institutional investors. 0.7% of Lumexa Imaging shares are held by insiders. Comparatively, 5.3% of Aveanna Healthcare shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

In the previous week, Aveanna Healthcare had 9 more articles in the media than Lumexa Imaging. MarketBeat recorded 11 mentions for Aveanna Healthcare and 2 mentions for Lumexa Imaging. Lumexa Imaging's average media sentiment score of 1.17 beat Aveanna Healthcare's score of 1.14 indicating that Lumexa Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Aveanna Healthcare	8 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Lumexa Imaging presently has a consensus target price of $17.33, suggesting a potential upside of 42.31%. Aveanna Healthcare has a consensus target price of $13.50, suggesting a potential downside of 0.59%. Given Lumexa Imaging's higher possible upside, research analysts clearly believe Lumexa Imaging is more favorable than Aveanna Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
Aveanna Healthcare	0 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.67

Summary

Aveanna Healthcare beats Lumexa Imaging on 11 of the 14 factors compared between the two stocks.

How does Lumexa Imaging compare to GeneDx?

Lumexa Imaging (NASDAQ:LMRI) and GeneDx (NASDAQ:WGS) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, earnings, valuation, media sentiment, analyst recommendations, risk, institutional ownership and dividends.

61.7% of GeneDx shares are owned by institutional investors. 0.7% of Lumexa Imaging shares are owned by company insiders. Comparatively, 25.2% of GeneDx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Lumexa Imaging has a net margin of 0.00% compared to GeneDx's net margin of -23.41%. GeneDx's return on equity of 4.12% beat Lumexa Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Lumexa Imaging	N/A	N/A	N/A
GeneDx	-23.41%	4.12%	2.26%

In the previous week, Lumexa Imaging had 1 more articles in the media than GeneDx. MarketBeat recorded 2 mentions for Lumexa Imaging and 1 mentions for GeneDx. GeneDx's average media sentiment score of 1.73 beat Lumexa Imaging's score of 1.17 indicating that GeneDx is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Lumexa Imaging	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
GeneDx	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive

Lumexa Imaging presently has a consensus price target of $17.33, suggesting a potential upside of 42.31%. GeneDx has a consensus price target of $89.57, suggesting a potential upside of 4.16%. Given Lumexa Imaging's higher probable upside, equities analysts plainly believe Lumexa Imaging is more favorable than GeneDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lumexa Imaging	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.67
GeneDx	1 Sell rating(s)	0 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.89

GeneDx has higher revenue and earnings than Lumexa Imaging. Lumexa Imaging is trading at a lower price-to-earnings ratio than GeneDx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lumexa Imaging	$267.73M	4.37	-$47.10M	-$0.49	N/A
GeneDx	$454.43M	5.64	-$21.02M	-$3.64	N/A

Summary

GeneDx beats Lumexa Imaging on 11 of the 15 factors compared between the two stocks.

Get Lumexa Imaging News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding LMRI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

LMRI vs. The Competition

Export

Metric	Lumexa Imaging	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.17B	$10.00B	$7.24B	$12.91B
Dividend Yield	N/A	2.59%	2.53%	9.14%
P/E Ratio	-24.86	34.60	274.10	25.45
Price / Sales	4.37	5.71	687.92	126.65
Price / Cash	35.03	121.42	77.08	52.44
Price / Book	1.90	3.99	12.85	6.17
Net Income	-$47.10M	$313.25M	$3.49B	$350.08M
7 Day Performance	5.82%	1.06%	1.04%	-0.14%
1 Month Performance	6.47%	1.22%	5.39%	0.94%
1 Year Performance	N/A	15.34%	24.18%	14.02%

Lumexa Imaging Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
LMRI Lumexa Imaging	3.8377 of 5 stars	$12.18 +2.4%	$17.33 +42.3%	N/A	$1.17B	$267.73M	N/A	5,019	Positive News
BLLN Billiontoone	4.1834 of 5 stars	$95.15 -1.1%	$126.71 +33.2%	N/A	$4.54B	$305.11M	135.93	620	News Coverage Analyst Forecast
OPCH Option Care Health	4.33 of 5 stars	$23.98 -0.2%	$29.92 +24.8%	-16.8%	$3.60B	$5.65B	18.03	8,266	News Coverage Positive News
CRVL CorVel	1.4366 of 5 stars	$69.43 -1.3%	N/A	-20.2%	$3.59B	$983.74M	30.86	5,239	News Coverage Positive News Analyst Upgrade Insider Trade
AVAH Aveanna Healthcare	3.7261 of 5 stars	$13.82 +1.5%	$12.89 -6.7%	+65.2%	$2.97B	$2.43B	11.24	35,500	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:LMRI) was last updated on 9/6/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Lumexa Imaging (LMRI) Competitors

LMRI vs. BLLN, OPCH, CRVL, AVAH, and WGS

How does Lumexa Imaging compare to Billiontoone?

Summary

How does Lumexa Imaging compare to Option Care Health?

Summary

How does Lumexa Imaging compare to CorVel?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Summary

How does Lumexa Imaging compare to GeneDx?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Lumexa Imaging (LMRI) Competitors

LMRI vs. BLLN, OPCH, CRVL, AVAH, and WGS

How does Lumexa Imaging compare to Billiontoone?

Does the media prefer BLLN or LMRI?

Which has better valuation and earnings, BLLN or LMRI?

Is BLLN or LMRI more profitable?

Do analysts rate BLLN or LMRI?

Summary

How does Lumexa Imaging compare to Option Care Health?

Which has preferable valuation & earnings, LMRI or OPCH?

Does the media prefer LMRI or OPCH?

Do analysts prefer LMRI or OPCH?

Do institutionals and insiders believe in LMRI or OPCH?

Is LMRI or OPCH more profitable?

Summary

How does Lumexa Imaging compare to CorVel?

Is CRVL or LMRI more profitable?

Do institutionals & insiders hold more shares of CRVL or LMRI?

Which has preferable earnings and valuation, CRVL or LMRI?

Do analysts prefer CRVL or LMRI?

Does the media favor CRVL or LMRI?

Summary

How does Lumexa Imaging compare to Aveanna Healthcare?

Which has stronger earnings and valuation, LMRI or AVAH?

Is LMRI or AVAH more profitable?

Do insiders & institutionals hold more shares of LMRI or AVAH?

Does the media favor LMRI or AVAH?

Do analysts prefer LMRI or AVAH?

Summary

How does Lumexa Imaging compare to GeneDx?

Do institutionals and insiders have more ownership in LMRI or WGS?

Is LMRI or WGS more profitable?

Does the media favor LMRI or WGS?

Do analysts rate LMRI or WGS?

Which has stronger valuation and earnings, LMRI or WGS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

LMRI vs. The Competition

Lumexa Imaging Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools